Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
An Integrated in Silico Screening Strategy for Identifying Promising Disruptors of P53-Mdm2 Interaction Publisher Pubmed



Sirous H1 ; Chemi G2 ; Campiani G2 ; Brogi S3
Authors

Source: Computational Biology and Chemistry Published:2019


Abstract

The p53 protein, also called guardian of the genome, plays a critical role in the cell cycle regulation and apoptosis. This protein is frequently inactivated in several types of human cancer by abnormally high levels of its negative regulator, mouse double minute 2 (MDM2). As a result, restoration of p53 function by inhibiting p53-MDM2 protein–protein interaction has been pursued as a compelling strategy for cancer therapy. To date, a limited number of small-molecules have been reported as effective p53−MDM2 inhibitors. X-ray structures of MDM2 in complex with some ligands are available in Protein Data Bank and herein, these data have been exploited to efficiently identify new p53-MDM2 interaction antagonists through a hierarchical virtual screening strategy. For this purpose, the first step was aimed at compiling a focused library of 686,630 structurally suitable compounds, from PubChem database, similar to two known effective inhibitors, Nutlin-3a and DP222669. These compounds were subjected to the subsequent structure-based approaches (quantum polarized ligand docking and molecular dynamics simulation) to select potential compounds with highest binding affinity for MDM2 protein. Additionally, ligand binding energy, ADMET properties and PAINS analysis were also considered as filtering criteria for selecting the most promising drug-like molecules. On the basis of these analyses, three top-ranked hit molecules, CID_118439641, CID_60452010 and CID_3106907, were found to have acceptable pharmacokinetics properties along with superior in silico inhibitory ability towards the p53-MDM2 interaction compared to known inhibitors. Molecular docking and molecular dynamics results well confirmed the interactions of the final selected compounds with critical residues within p53 binding site on the MDM2 hydrophobic clefts with satisfactory thermodynamics stability. Consequently, the new final scaffolds identified by the presented computational approach could offer a set of guidelines for designing promising anti-cancer agents targeting p53-MDM2 interaction. © 2019 Elsevier Ltd
Related Docs
View other Related Docs
1. Discovery of Novel Hit Compounds As Potential Hdac1 Inhibitors: The Case of Ligand- and Structure-Based Virtual Screening, Computers in Biology and Medicine (2021)
2. Identification of Novel 3-Hydroxy-Pyran-4-One Derivatives As Potent Hiv-1 Integrase Inhibitors Using in Silico Structure-Based Combinatorial Library Design Approach, Frontiers in Chemistry (2019)
3. Discovery of Novel Direct Small-Molecule Inhibitors Targeting Hif-2Α Using Structure-Based Virtual Screening, Molecular Dynamics Simulation, and Mm-Gbsa Calculations, Molecular Diversity (2024)
Experts (# of related papers)
View all Related Experts
Afshin Fassihi (5)
Hojjat Sadeghi-Aliabadi (3)
Other Related Docs
4. Synthesis, Molecular Modelling and Biological Studies of 3-Hydroxy-Pyrane-4-One and 3-Hydroxy-Pyridine-4-One Derivatives As Hiv-1 Integrase Inhibitors, Medicinal Chemistry (2019)
5. Pyrimido[4,5-B]Indole Derivatives Bearing 1,2,4-Oxadiazole Moiety As Mdm2 Inhibitor Candidates in Cancer Treatment, Future Medicinal Chemistry (2023)
6. Disruption of Irisin Dimerization by Fda-Approved Drugs: A Computational Repurposing Approach for the Potential Treatment of Lipodystrophy Syndromes, International Journal of Molecular Sciences (2023)
7. Preparing a Database of Corrected Protein Structures Important in Cell Signaling Pathways, Research in Pharmaceutical Sciences (2023)
8. Prediction of Dual Nf-Κb/Iκb Inhibitors Using an Integrative In-Silico Approaches, Journal of Biomolecular Structure and Dynamics (2023)
9. In Silico Identification of Natural Products and World-Approved Drugs Targeting the Keap1/Nrf2 Pathway Endowed With Potential Antioxidant Profile, Computation (2023)
10. Structure-Based High-Throughput Virtual Screening and Molecular Dynamics Simulation for the Discovery of Novel Sars-Cov-2 Nsp3 Mac1 Domain Inhibitors, Viruses (2023)
11. Dihydropyrimidine Derivatives As Mdm2 Inhibitors, Chemical Biology and Drug Design (2024)
12. Amyloid ß Fibril Disruption by Oleuropein Aglycone: Long-Time Molecular Dynamics Simulation to Gain Insight Into the Mechanism of Action of This Polyphenol From Extra Virgin Olive Oil, Food and Function (2020)
13. Computer-Driven Development of an in Silico Tool for Finding Selective Histone Deacetylase 1 Inhibitors, Molecules (2020)
14. Combining Subtractive Genomics With Computer-Aided Drug Discovery Techniques to Effectively Target S. Sputigena in Periodontitis, Computation (2025)
15. An In-Silico Screening Strategy to the Prediction of New Inhibitors of Covid-19 Mpro Protein, Iranian Journal of Pharmaceutical Research (2021)
16. Exosomes As Efficient Platforms for Delivering Adenosine-Tetra Peptide Conjugate to Pancreatic Cancer Cells: An in Vitro/In Silico Study, Journal of Drug Delivery Science and Technology (2023)
17. Quantitative Structure–Activity Relationship Modeling and Molecular Docking Studies of Tgcdpk1 Inhibitors in Toxoplasma Gondii, MicrobiologyOpen (2025)
18. Structural Analysis of Some Pyrrolopyrimidine Derivatives and Examining Their Binding Affinity Against the Cyclooxygenase-2 Enzyme, Turkish Computational and Theoretical Chemistry (2021)
19. Discovery of Novel Rarα Agonists Using Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Studies, PLoS ONE (2023)
20. Prediction of Dual Agents As an Activator of Mutant P53 and Inhibitor of Hsp90 by Docking, Molecular Dynamic Simulation and Virtual Screening, Journal of Molecular Graphics and Modelling (2015)